Fibrosis
Scarring within the lungs that can create reticular, coarse, or volume-loss patterns on imaging
Fibrosis refers to scarring within lung tissue and may appear on chest X-ray as coarse linear opacity, reticulation, distortion, or volume loss.
Pulmonary fibrosis means the lungs have developed scar tissue. It can make breathing less efficient and may relate to prior injury, chronic inflammation, autoimmune disease, occupational exposure, or interstitial lung disease.
Representative X-ray
Representative annotated X-ray not available for this topic yet.
We only show a representative image when there is a clean corresponding source in the current reference set.
What it is
- This is a radiographic and clinical concept referring to chronic scarring in the lung interstitium
- Chest X-ray may suggest fibrosis, but CT usually shows the pattern much more clearly
How it appears on chest X-ray
- On chest X-ray, fibrosis can appear as reticular opacities, coarse linear scarring, volume loss, architectural distortion, or chronic asymmetry depending on the cause and severity
What radiologists look for
- Radiologists look for whether the pattern is focal or diffuse, upper or lower lobe predominant, associated with honeycombing or traction changes on CT, and whether prior imaging shows progression
How X-ray helps
- X-ray can suggest chronic scarring, but CT is often needed to define the pattern, extent, and likely differential diagnosis
Common causes
- Causes include interstitial lung disease, prior infection, radiation, autoimmune disease, occupational exposure, drug toxicity, and idiopathic pulmonary fibrosis
Symptoms / associated symptoms
- Symptoms can include shortness of breath, chronic cough, reduced exercise tolerance, fatigue, or no obvious symptoms early in disease
Risk factors
- Risk factors include smoking, occupational exposures, autoimmune disease, radiation, certain medications, and older age in some fibrotic syndromes
Why it can matter clinically
- Complications can include worsening breathlessness, hypoxemia, reduced lung capacity, pulmonary hypertension, and progressive respiratory failure in severe disease
When to seek medical care
- Seek medical review for persistent shortness of breath, chronic cough, falling exercise tolerance, or abnormal imaging suggesting chronic lung scarring
Evaluation and diagnosis
- Evaluation may include CT chest, pulmonary function testing, exposure history, autoimmune workup, and pulmonary specialist review
Treatment approaches
- Management may include treating the cause, pulmonary follow-up, pulmonary rehab, oxygen support, antifibrotic therapy in selected diseases, and monitoring for progression
Medication classes clinicians may use
Medication depends on the underlying fibrotic process and may involve anti-inflammatory, immunomodulatory, antifibrotic, or supportive therapy.
Treatment modalities commonly paired with medication decisions
- Pulmonary specialist care
- Cause-directed therapy
- Pulmonary rehabilitation
- Oxygen support when needed
Antifibrotic therapies
Used in selected fibrotic lung diseases under specialist guidance to slow progression.
- nintedanib
- pirfenidone
FAQ
Can chest X-ray diagnose pulmonary fibrosis by itself?
Not reliably. It can suggest chronic scarring, but CT is often needed to characterize the pattern and extent.
Is fibrosis reversible?
Established scar tissue is generally not fully reversible, so management often focuses on cause, symptoms, and slowing progression.